Mankind Pharma Limited — Capital/Financing Update 2025

Oct 29, 2025

==> picture [559 x 53] intentionally omitted <==

October 29, 2025

BSE Limited P J Towers, Dalal Street, Mumbai – 400 001

Scrip Code: 543904

National Stock Exchange of India Limited Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051

Symbol: MANKIND

Dear Sir/ Madam,

Subject: Intimation regarding withdrawal/re-affirmation of Credit Rating

Ref.: Regulation 30 & 51 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)

Pursuant to Regulations 30 and 51 of the Listing Regulations read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, we wish to inform you that CRISIL Ratings Limited vide its letter dated October 29, 2025 has withdrawn/reaffirmed the credit rating for the following instruments of the Company:

==> picture [429 x 85] intentionally omitted <==

----- Start of picture text -----

Instruments Amount Rating Rating
(₹ in crore) Action
Total Bank Loan Facilities Rated 1,250 Crisil AA+/Stable Withdrawn
Non Convertible Debentures 400 Crisil AA+/Stable Reaffirmed
Non Convertible Debentures 4,600 Crisil AA+/Stable Reaffirmed
Commercial Paper 1,500 Crisil A1+ Reaffirmed
----- End of picture text -----*

*Reduced from ₹5,000 Crores to ₹1,500 Crores.

The above information is also available on the website of the Company at www.mankindpharma.com.

This is for your information and records.

Thanking You,

Yours Faithfully,

For Mankind Pharma Limited

Digitally signed by HITESH HITESH KUMAR JAIN KUMAR JAIN Date: 2025.10.29 18:00:11 +05'30' Hitesh Kumar Jain Company Secretary & Compliance Officer

==> picture [557 x 60] intentionally omitted <==